Taiko Pharmaceutical Co.,Ltd. provided earnings guidance for the year ending December 2023. For the year, the company's net sales to be ¥7,900 million, operating profit to be ¥532 million, net income to be ¥50 million or Basic earnings per share to be ¥1.15.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
416 JPY | -0.95% |
|
+6.12% | +37.29% |
1st Jan change | Capi. | |
---|---|---|
+37.29% | 130M | |
+20.76% | 43.77B | |
+28.00% | 22.83B | |
+20.25% | 15.56B | |
+18.82% | 14.34B | |
+55.83% | 12.96B | |
-0.05% | 6.79B | |
-12.70% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- 4574 Stock
- News Taiko Pharmaceutical Co.,Ltd.
- Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2023